Aziz Mottiwala insider trades

Open-market stock purchases and sales by Aziz Mottiwala, President and CEO at RxSight, Inc, from SEC Form 4 filings since Jan 7, 2021.

Recent trades

DateStockTradeValue
Jul 24, 2026RXST RxSight, IncBought (not open market)—
Jul 24, 2026RXST RxSight, IncBought (not open market)—
Mar 19, 2026TARS Tarsus Pharmaceuticals, IncSold$297K
Mar 18, 2026TARS Tarsus Pharmaceuticals, IncSold$298K
Mar 17, 2026TARS Tarsus Pharmaceuticals, IncSold$298K
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—

Companies traded

  • RXST RxSight, Inc: other filings, last Jul 24, 2026
  • TARS Tarsus Pharmaceuticals, Inc: 25 sales, last Mar 19, 2026

Get free alerts when Aziz Mottiwala files a new trade →